UBS Group’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | – | Sell |
-1,786
| Closed | -$54 | – | 11760 |
|
|
2026
Q2 | $54 | Buy |
1,786
+200
| +13% | +$8 | ﹤0.01% | 10184 |
|
|
2026
Q1 | $56 | Sell |
1,586
-915
| -37% | -$52 | ﹤0.01% | 10193 |
|
|
2025
Q4 | $195 | Buy |
2,501
+1,899
| +315% | +$202 | ﹤0.01% | 10117 |
|
|
2025
Q3 | $10 | Sell |
602
-1,885
| -76% | -$72 | ﹤0.01% | 10193 |
|
|
2025
Q2 | $87 | Hold |
2,487
| – | – | ﹤0.01% | 10015 |
|
|
2025
Q1 | $147 | Sell |
2,487
-525
| -17% | -$26 | ﹤0.01% | 9919 |
|
|
2024
Q4 | $151 | Sell |
3,012
-2,446
| -45% | -$130 | ﹤0.01% | 9600 |
|
|
2024
Q3 | $218 | Sell |
5,458
-942
| -15% | -$102 | ﹤0.01% | 9057 |
|
|
2024
Q2 | $1.38K | Buy |
+6,400
| New | +$964 | ﹤0.01% | 8583 |
|
|
2023
Q4 | – | Sell |
-145
| Closed | -$3 | – | 9991 |
|
|
2023
Q3 | $3 | Sell |
145
-135
| -48% | -$4 | ﹤0.01% | 9329 |
|
|
2023
Q2 | $18 | Buy |
+280
| New | +$23 | ﹤0.01% | 8697 |
|
|
2023
Q1 | – | Sell |
-4,710
| Closed | -$471 | – | 10533 |
|
|
2022
Q4 | $471 | Sell |
4,710
-4,920
| -51% | -$519 | ﹤0.01% | 10170 |
|
|
2022
Q3 | $1K | Hold |
9,630
| – | – | ﹤0.01% | 10062 |
|
|
2022
Q2 | $1K | Buy |
+9,630
| New | +$1.38K | ﹤0.01% | 9992 |
|
UBS Group's VSEEW Position: Q3 2026 in Review
UBS Group sold out of VSEE HEALTH INC WTS 29 (VSEEW) in Q3 2026, closing a stake of 1,786 shares — an estimated $54 sold.
UBS Group first reported a position in VSEEW in Q2 2022 and held it in 14 quarters. The position peaked at $1.38K in Q2 2024. 0 funds tracked by Wall St. Rank hold VSEEW as of Q3 2026.
- UBS Group reported no remaining VSEE HEALTH INC WTS 29 position as of Q3 2026 after selling out during the quarter.
- UBS Group sold 1,786 VSEE HEALTH INC WTS 29 shares in Q3 2026, an estimated $54.
- UBS Group first reported a position in VSEE HEALTH INC WTS 29 in Q2 2022 and held it in 14 quarters.
- UBS Group's VSEE HEALTH INC WTS 29 position peaked at $1.38K in Q2 2024.
- 0 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.